Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · IEX Real-Time Price · USD
1.000
-0.040 (-3.85%)
At close: Mar 28, 2024, 4:00 PM
0.990
-0.010 (-1.00%)
After-hours: Mar 28, 2024, 4:48 PM EDT

Alzamend Neuro Cash Flow Statement

Millions USD. Fiscal year is May - Apr.
Year 20232022202120202019
Net Income
-14.88-12.36-5.05-4.41-4.86
Depreciation & Amortization
0.020000
Share-Based Compensation
3.584.412.031.80.4
Other Operating Activities
2.351.340.30.263.42
Operating Cash Flow
-8.92-6.61-2.71-2.35-1.05
Capital Expenditures
0-0.11000
Acquisitions
000.10.110.23
Investing Cash Flow
0-0.110.10.110.23
Share Issuance / Repurchase
018.912.22.310.24
Debt Issued / Paid
0-0.062.25-0.020.07
Financing Cash Flow
018.854.452.290.31
Net Cash Flow
-8.9212.131.840.05-0.5
Free Cash Flow
-8.92-6.72-2.71-2.35-1.05
Free Cash Flow Per Share
-1.37-1.13-0.56-0.49-0.27
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).